NBIX
Neurocrine Biosciences, Inc. β’ Healthcare (#5 of 11)
$132.56
+0.82 (+0.62%)
View:
Close:$132.56
Vol:HIGH(75%ile)
Ratio:1.06x
|RSI:55(Neutral)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²0 UpβΌ0 Down1 Hold
Mar 12JP Morgan
βOverweight
Price Targets
(60d mean: $170, +28.3%)β²1 RaisesβΌ0 Lowers+0.6% avg
Mar 12JP Morgan
$176β$177+0.6%
Trade Setup
Entry$132.56
Target$139.72 (+5.4%)
Stop$125.40
R/R1.00
Risk-5.4%
Conv32 (LOW)
Size61 shares ($8,086)
Risk Metrics
Sharpe (20d)
-0.24Losing
Volatility (20d)
23.9%Low
Beta (60d)
0.80Average
Alpha (20d)
+3.6%Moderate+
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.